Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP. [electronic resource]
Producer: 20050222Description: 275-81 p. digitalISSN:- 0270-4137
- Adenocarcinoma -- blood
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- blood
- Bone Neoplasms -- blood
- Calcium -- blood
- Carrier Proteins -- blood
- Cell Line, Tumor
- Diphosphonates -- pharmacology
- Disease Models, Animal
- Glycoproteins -- blood
- Green Fluorescent Proteins -- biosynthesis
- Humans
- Interleukin-6 -- blood
- Interleukin-8 -- blood
- Male
- Membrane Glycoproteins -- blood
- Mice
- Mice, SCID
- Microscopy, Fluorescence
- Osteoprotegerin
- Pamidronate
- Parathyroid Hormone-Related Protein -- blood
- Prostatic Neoplasms -- blood
- RANK Ligand
- Radiography
- Receptor Activator of Nuclear Factor-kappa B
- Receptors, Cytoplasmic and Nuclear -- blood
- Receptors, Tumor Necrosis Factor
- Transduction, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.